Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.501EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.226EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.546EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.429.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.9 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.203EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.157EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.176EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
B.1.393EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.388EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.112EWon-ECACACAATCGATGCGCAGTA20502636526346R-8964.71South Korea
B.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.515EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.118EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.137EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used